Morgan Stanley analyst Christopher Snyder maintained a Hold rating on Hubbell B (HUBB – Research Report) today and set a price target of $445.00. The company’s shares closed yesterday at $433.92.

Sickle Cell Disease is a genetic blood disorder that affects millions worldwide, primarily individuals of African, Mediterranean, Middle Eastern, and Indian ancestry. The condition is ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

The majority of our patients with ocular hypertension maintained IOP between 10 and 21 mm Hg across all treatment groups over time. Bai et al [4] also reported successful IOP control in their ...

Our study demonstrated that PCP had higher complete success rate and survival rates at 12, 18, and 24 months than phaco alone (Figure 1). Although the PCP group had lower VA than the phaco group ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.